Inatriauofanew antihistaminedrua.1ineverv5batientstreated95%confidenceintervauforthenumber
neededtotreatNNT)forreduced svmotoms:lin3to1inl0) wasfoundtohavesianifcanttyreduced
symptomsonavalidatedhayfever symptom scoretwoweeks after commemcing thedrug.compared with
placebo
Whatisthemostcorrect interpretation oftheresutsofthisstudy?
5%ofpatientsdidnothavereducedsymptomsafter 2weeks on thenewdrug
Theeffectofthenewdruqisnotsiqnificanty differentfromplacebo
Thenumberneededtotreat NNT) statistic presentedis inappropriateforthis typeof study
The statistical significance ofthisresut cannotbedetermined as noP-valueisreported
wecan be95%certain thatbetween10and 33of patients wilbemeftfromthenew drug
@1MIN NDOCRINE
